Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
Not Applicable
- Conditions
- Autosomal dominant polycystic kidney disease (ADPKD)
- Registration Number
- JPRN-jRCT1080221699
- Lead Sponsor
- Otsuka Pharmaceutical Dvelopment & Commercialization, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
1) Existing diagnosis of ADPKD by modified-Ravine criteria
2) Total kidney volume >= 300 cc/m height by ultrasound or >= 250 cc/m height by MRI
Exclusion Criteria
1) Current or expected (within the next six months) interventions for the treatment of ADPKD affecting kidney volume
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of change in total kidney volume with ADPKD-related outcomes<br>every 1 year
- Secondary Outcome Measures
Name Time Method Patient-reported pain<br>every 6 months<br>SF-12 Scores<br>every 6 months<br>ADPKD-Impact Scale Scores<br>every 6 months<br>Cost of care<br>every 6 months<br>EuroQuol-5D Scores<br>every 6 months